Expression of YKL-40, an Inflammatory Glycoprotein and its Prognostic Implications in Cancer (original) (raw)

YKL-40/CHI3L1 drives inflammation on the road of tumor progression

Stephania Libreros

Journal of Leukocyte Biology, 2015

View PDFchevron_right

Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

Banu çaycı

Advances in Therapy, 2008

View PDFchevron_right

Role of YKL-40 in cutaneous and systemic diseases

yomna mazid

International Journal of Dermatology, Venereology and Leprosy Sciences

View PDFchevron_right

Increased expression of the inflammatory protein YKL-40 in precancers of the breast

Weizhu Zhu

International Journal of Cancer, 2007

View PDFchevron_right

High serum YKL-40 level is associated with poor prognosis in patients with lung cancer

İsmail Savaş

Tuberkuloz ve Toraks

View PDFchevron_right

Clinical Significance of Serum YKL-40 and its Correlation with Serum IL6 and CRP in Breast Cancer Patients

Enas A Elkhouly

Research in Oncology, 2014

View PDFchevron_right

Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?

Benny Jensen

Cancer Epidemiology Biomarkers & Prevention, 2006

View PDFchevron_right

Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells

Peter Nørgaard

European Journal of Haematology, 2006

View PDFchevron_right

High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival

Katalin Kiss, Eva Balslev

International Journal of Cancer, 2008

View PDFchevron_right

Diverse pathological implications of YKL-40: Answers may lie in ‘outside-in’ signaling

divya prakash

Cellular Signalling, 2013

View PDFchevron_right

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis

Jihjong Lee

Journal of Veterinary Science

View PDFchevron_right

Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers

Richard B Arenas MD

Breast Diseases: A Year Book Quarterly, 2012

View PDFchevron_right

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival

Julia Johansen

Oncology Reports, 2003

View PDFchevron_right

YKL-40 in Healthy Subjects

V. Sarafian

2010

View PDFchevron_right

Overexpression of YKL-40 is an independent prognostic marker in gastric cancer

Xin-yuan Guan

Human Pathology, 2009

View PDFchevron_right

Serum YKL-40 Levels in Patients with Gastric Cancer

Ozgur Kemik

Biomarkers in Cancer, 2011

View PDFchevron_right

Utility of serum YKL-40 as a tumor-specific marker of hepatobiliary malignancies

Surakit Pungpapong

2010

View PDFchevron_right

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis

Richard B Arenas MD

Oncogene, 2009

View PDFchevron_right

Assessment of importance of YKL-40 protein as biomarker in colorectal cancer and its relation to selected clinical and pathological parameters

Zbigniew Lorenc

Annales Academiae Medicae Silesiensis, 2021

View PDFchevron_right

Prognostic effect of serum and tissue YKL-40 levels in bladder cancer

Péter Nyirády

Urologic Oncology: Seminars and Original Investigations, 2014

View PDFchevron_right

Overexpression of chitinase like protein YKL-40 in leukemia patients

Saksham Yadav

View PDFchevron_right

High serum YKL-40 level in patients with small cell lung cancer is related to early death

Julia Johansen

Lung Cancer, 2004

View PDFchevron_right

Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia

Mónica Saavedra-Herrera

Molecular and Clinical Oncology, 2021

View PDFchevron_right

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells

Varinder Jeet, M. Lehman

Endocrine Related Cancer, 2014

View PDFchevron_right

Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma

Ozgur Kemik

Cancer Growth and Metastasis, 2011

View PDFchevron_right

YKL-40 - a New Diagnostic Biomarker for Benign Breast Diseases and Breast Cancer

V. Sarafian

2010

View PDFchevron_right

Chitinase-3-Like Protein1 (YKL-40) as Biomarker in Serum of Egyptian Breast Cancer Females

Olfat Shaker

Biochemistry & Analytical Biochemistry, 2014

View PDFchevron_right

Elevated Serum YKL-40 Level Predicts Poor Prognosis in Hepatocellular Carcinoma After Surgery

Jian Tian

Annals of Surgical Oncology, 2012

View PDFchevron_right

YKL-40 – a New Diagnostic Biomarcer for Benign Breast Diseases and Breast Cancer

K. Murdjev, Albena Paskaleva

Journal of IMAB - Annual Proceeding (Scientific Papers), 2010

View PDFchevron_right

Ykl-40 and cancer antigen 72-4 as new and promising diagnostic and prognostic markers for endometrial cancer

Nigar Sofiyeva

Journal of Turkish Society of Obstetric and Gynecology

View PDFchevron_right

Protein and mRNA Levels of YKL-40 in High-Grade Glioma

Dessislava Staneva

Folia biologica

View PDFchevron_right